Everand Logo

Welcome to Everand!

  • STAT

    CAR-T startup Allogene Therapeutics picks up veteran analyst Eric Schmidt as CFO

    by Adam Feuerstein Jun 18, 2018 3 minutes

    Veteran Cowen biotech analyst Eric Schmidt is joining Allogene Therapeutics, the new CAR-T cancer therapy startup, as its chief financial officer.

    The formal announcement was made Monday in a joint statement issued by Allogene and Cowen. Arie Belldegrun, the former Kite Pharma CEO and now co-founder and chairman of Allogene, had been recruiting Schmidt for some time, as previously reported by STAT in May.

    Schmidt is one of Wall Street’s longest-tenured biotech research analysts, widely respected and followed

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
    Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
    STAT2 min read
    STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
    A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
    A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

    Related